Global Viral Testing Market Research Report 2021

Publisher Name :
Date: 23-Mar-2021
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Direct Fluorescent Antibody (DFA) Test

- Immunochromatographic Assay

- RT-PCR-Based Test

- Agglutination Assay

- Flow-Through Assay

- Solid-Phase Assay

Segment by Application

- Laboratory

- Hospital

- Home Care

- Academic Institute

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Roche

- Agilent Technologies

- Thermo Fisher Scientific

- QIAGEN International

- Lonza

- Wuxi Pharmatech (Cayman)

- Merck

- Eurofins Scientific

- General Electric

- Danaher

- Bio-Rad Laboratories

- BD

- Biospherix

- Novogene Corporation

- Sartorius

Global Viral Testing Market Research Report 2021

Table of Contents
1 Viral Testing Market Overview
1.1 Product Overview and Scope of Viral Testing
1.2 Viral Testing Segment by Type
1.2.1 Global Viral Testing Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Direct Fluorescent Antibody (DFA) Test
1.2.3 Immunochromatographic Assay
1.2.4 RT-PCR-Based Test
1.2.5 Agglutination Assay
1.2.6 Flow-Through Assay
1.2.7 Solid-Phase Assay
1.3 Viral Testing Segment by Application
1.3.1 Viral Testing Sales Comparison by Application: (2021-2027)
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Home Care
1.3.5 Academic Institute
1.4 Global Viral Testing Market Size Estimates and Forecasts
1.4.1 Global Viral Testing Revenue 2016-2027
1.4.2 Global Viral Testing Sales 2016-2027
1.4.3 Viral Testing Market Size by Region: 2016 Versus 2021 Versus 2027
2 Viral Testing Market Competition by Manufacturers
2.1 Global Viral Testing Sales Market Share by Manufacturers (2016-2021)
2.2 Global Viral Testing Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Viral Testing Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Viral Testing Manufacturing Sites, Area Served, Product Type
2.5 Viral Testing Market Competitive Situation and Trends
2.5.1 Viral Testing Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Viral Testing Players Market Share by Revenue
2.5.3 Global Viral Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Viral Testing Retrospective Market Scenario by Region
3.1 Global Viral Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Viral Testing Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Viral Testing Market Facts & Figures by Country
3.3.1 North America Viral Testing Sales by Country
3.3.2 North America Viral Testing Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Viral Testing Market Facts & Figures by Country
3.4.1 Europe Viral Testing Sales by Country
3.4.2 Europe Viral Testing Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Viral Testing Market Facts & Figures by Region
3.5.1 Asia Pacific Viral Testing Sales by Region
3.5.2 Asia Pacific Viral Testing Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Viral Testing Market Facts & Figures by Country
3.6.1 Latin America Viral Testing Sales by Country
3.6.2 Latin America Viral Testing Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Viral Testing Market Facts & Figures by Country
3.7.1 Middle East and Africa Viral Testing Sales by Country
3.7.2 Middle East and Africa Viral Testing Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Viral Testing Historic Market Analysis by Type
4.1 Global Viral Testing Sales Market Share by Type (2016-2021)
4.2 Global Viral Testing Revenue Market Share by Type (2016-2021)
4.3 Global Viral Testing Price by Type (2016-2021)
5 Global Viral Testing Historic Market Analysis by Application
5.1 Global Viral Testing Sales Market Share by Application (2016-2021)
5.2 Global Viral Testing Revenue Market Share by Application (2016-2021)
5.3 Global Viral Testing Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Agilent Technologies
6.2.1 Agilent Technologies Corporation Information
6.2.2 Agilent Technologies Description and Business Overview
6.2.3 Agilent Technologies Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Agilent Technologies Product Portfolio
6.2.5 Agilent Technologies Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Corporation Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Thermo Fisher Scientific Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 QIAGEN International
6.4.1 QIAGEN International Corporation Information
6.4.2 QIAGEN International Description and Business Overview
6.4.3 QIAGEN International Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 QIAGEN International Product Portfolio
6.4.5 QIAGEN International Recent Developments/Updates
6.5 Lonza
6.5.1 Lonza Corporation Information
6.5.2 Lonza Description and Business Overview
6.5.3 Lonza Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lonza Product Portfolio
6.5.5 Lonza Recent Developments/Updates
6.6 Wuxi Pharmatech (Cayman)
6.6.1 Wuxi Pharmatech (Cayman) Corporation Information
6.6.2 Wuxi Pharmatech (Cayman) Description and Business Overview
6.6.3 Wuxi Pharmatech (Cayman) Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Wuxi Pharmatech (Cayman) Product Portfolio
6.6.5 Wuxi Pharmatech (Cayman) Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Eurofins Scientific
6.8.1 Eurofins Scientific Corporation Information
6.8.2 Eurofins Scientific Description and Business Overview
6.8.3 Eurofins Scientific Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Eurofins Scientific Product Portfolio
6.8.5 Eurofins Scientific Recent Developments/Updates
6.9 General Electric
6.9.1 General Electric Corporation Information
6.9.2 General Electric Description and Business Overview
6.9.3 General Electric Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.9.4 General Electric Product Portfolio
6.9.5 General Electric Recent Developments/Updates
6.10 Danaher
6.10.1 Danaher Corporation Information
6.10.2 Danaher Description and Business Overview
6.10.3 Danaher Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Danaher Product Portfolio
6.10.5 Danaher Recent Developments/Updates
6.11 Bio-Rad Laboratories
6.11.1 Bio-Rad Laboratories Corporation Information
6.11.2 Bio-Rad Laboratories Viral Testing Description and Business Overview
6.11.3 Bio-Rad Laboratories Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Bio-Rad Laboratories Product Portfolio
6.11.5 Bio-Rad Laboratories Recent Developments/Updates
6.12 BD
6.12.1 BD Corporation Information
6.12.2 BD Viral Testing Description and Business Overview
6.12.3 BD Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.12.4 BD Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 Biospherix
6.13.1 Biospherix Corporation Information
6.13.2 Biospherix Viral Testing Description and Business Overview
6.13.3 Biospherix Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Biospherix Product Portfolio
6.13.5 Biospherix Recent Developments/Updates
6.14 Novogene Corporation
6.14.1 Novogene Corporation Corporation Information
6.14.2 Novogene Corporation Viral Testing Description and Business Overview
6.14.3 Novogene Corporation Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novogene Corporation Product Portfolio
6.14.5 Novogene Corporation Recent Developments/Updates
6.15 Sartorius
6.15.1 Sartorius Corporation Information
6.15.2 Sartorius Viral Testing Description and Business Overview
6.15.3 Sartorius Viral Testing Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sartorius Product Portfolio
6.15.5 Sartorius Recent Developments/Updates
7 Viral Testing Manufacturing Cost Analysis
7.1 Viral Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Viral Testing
7.4 Viral Testing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Viral Testing Distributors List
8.3 Viral Testing Customers
9 Viral Testing Market Dynamics
9.1 Viral Testing Industry Trends
9.2 Viral Testing Growth Drivers
9.3 Viral Testing Market Challenges
9.4 Viral Testing Market Restraints
10 Global Market Forecast
10.1 Viral Testing Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Viral Testing by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Viral Testing by Type (2022-2027)
10.2 Viral Testing Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Viral Testing by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Viral Testing by Application (2022-2027)
10.3 Viral Testing Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Viral Testing by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Viral Testing by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Viral Testing Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Viral Testing Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Viral Testing Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Viral Testing Covered in This Study
Table 5. Global Viral Testing Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Viral Testing Sales Share by Manufacturers (2016-2021)
Table 7. Global Viral Testing Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Viral Testing Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Viral Testing Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Viral Testing Manufacturing Sites and Area Served
Table 11. Manufacturers Viral Testing Product Type
Table 12. Global Viral Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Viral Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Testing as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Viral Testing Sales by Region (2016-2021) & (K Units)
Table 16. Global Viral Testing Sales Market Share by Region (2016-2021)
Table 17. Global Viral Testing Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Viral Testing Sales by Country (2016-2021) & (K Units)
Table 19. North America Viral Testing Sales Market Share by Country (2016-2021)
Table 20. North America Viral Testing Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Viral Testing Revenue Market Share by Country (2016-2021)
Table 22. Europe Viral Testing Sales by Country (2016-2021) & (K Units)
Table 23. Europe Viral Testing Sales Market Share by Country (2016-2021)
Table 24. Europe Viral Testing Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Viral Testing Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Viral Testing Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Viral Testing Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Viral Testing Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Viral Testing Revenue Market Share by Region (2016-2021)
Table 30. Latin America Viral Testing Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Viral Testing Sales Market Share by Country (2016-2021)
Table 32. Latin America Viral Testing Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Viral Testing Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Viral Testing Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Viral Testing Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Viral Testing Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Viral Testing Revenue Market Share by Country (2016-2021)
Table 38. Global Viral Testing Sales (K Units) by Type (2016-2021)
Table 39. Global Viral Testing Sales Market Share by Type (2016-2021)
Table 40. Global Viral Testing Revenue (Million US$) by Type (2016-2021)
Table 41. Global Viral Testing Revenue Share by Type (2016-2021)
Table 42. Global Viral Testing Price (US$/Unit) by Type (2016-2021)
Table 43. Global Viral Testing Sales (K Units) by Application (2016-2021)
Table 44. Global Viral Testing Sales Market Share by Application (2016-2021)
Table 45. Global Viral Testing Revenue (Million US$) by Application (2016-2021)
Table 46. Global Viral Testing Revenue Share by Application (2016-2021)
Table 47. Global Viral Testing Price (US$/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Roche Viral Testing Product
Table 52. Roche Recent Developments/Updates
Table 53. Agilent Technologies Corporation Information
Table 54. Agilent Technologies Description and Business Overview
Table 55. Agilent Technologies Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Agilent Technologies Viral Testing Product
Table 57. Agilent Technologies Recent Developments/Updates
Table 58. Thermo Fisher Scientific Corporation Information
Table 59. Thermo Fisher Scientific Description and Business Overview
Table 60. Thermo Fisher Scientific Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Thermo Fisher Scientific Viral Testing Product
Table 62. Thermo Fisher Scientific Recent Developments/Updates
Table 63. QIAGEN International Corporation Information
Table 64. QIAGEN International Description and Business Overview
Table 65. QIAGEN International Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. QIAGEN International Viral Testing Product
Table 67. QIAGEN International Recent Developments/Updates
Table 68. Lonza Corporation Information
Table 69. Lonza Description and Business Overview
Table 70. Lonza Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Lonza Viral Testing Product
Table 72. Lonza Recent Developments/Updates
Table 73. Wuxi Pharmatech (Cayman) Corporation Information
Table 74. Wuxi Pharmatech (Cayman) Description and Business Overview
Table 75. Wuxi Pharmatech (Cayman) Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Wuxi Pharmatech (Cayman) Viral Testing Product
Table 77. Wuxi Pharmatech (Cayman) Recent Developments/Updates
Table 78. Merck Corporation Information
Table 79. Merck Description and Business Overview
Table 80. Merck Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Merck Viral Testing Product
Table 82. Merck Recent Developments/Updates
Table 83. Eurofins Scientific Corporation Information
Table 84. Eurofins Scientific Description and Business Overview
Table 85. Eurofins Scientific Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Eurofins Scientific Viral Testing Product
Table 87. Eurofins Scientific Recent Developments/Updates
Table 88. General Electric Corporation Information
Table 89. General Electric Description and Business Overview
Table 90. General Electric Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. General Electric Viral Testing Product
Table 92. General Electric Recent Developments/Updates
Table 93. Danaher Corporation Information
Table 94. Danaher Description and Business Overview
Table 95. Danaher Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Danaher Viral Testing Product
Table 97. Danaher Recent Developments/Updates
Table 98. Bio-Rad Laboratories Corporation Information
Table 99. Bio-Rad Laboratories Description and Business Overview
Table 100. Bio-Rad Laboratories Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Bio-Rad Laboratories Viral Testing Product
Table 102. Bio-Rad Laboratories Recent Developments/Updates
Table 103. BD Corporation Information
Table 104. BD Description and Business Overview
Table 105. BD Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. BD Viral Testing Product
Table 107. BD Recent Developments/Updates
Table 108. Biospherix Corporation Information
Table 109. Biospherix Description and Business Overview
Table 110. Biospherix Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Biospherix Viral Testing Product
Table 112. Biospherix Recent Developments/Updates
Table 113. Novogene Corporation Corporation Information
Table 114. Novogene Corporation Description and Business Overview
Table 115. Novogene Corporation Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Novogene Corporation Viral Testing Product
Table 117. Novogene Corporation Recent Developments/Updates
Table 118. Sartorius Corporation Information
Table 119. Sartorius Description and Business Overview
Table 120. Sartorius Viral Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Sartorius Viral Testing Product
Table 122. Sartorius Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Viral Testing Distributors List
Table 126. Viral Testing Customers List
Table 127. Viral Testing Market Trends
Table 128. Viral Testing Growth Drivers
Table 129. Viral Testing Market Restraints
Table 130. Global Viral Testing Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Viral Testing Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Viral Testing Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Viral Testing Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Viral Testing Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Viral Testing Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Viral Testing Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Viral Testing Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Viral Testing Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Viral Testing Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Viral Testing Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Viral Testing Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Viral Testing
Figure 2. Global Viral Testing Market Share by Type in 2020 & 2027
Figure 3. Direct Fluorescent Antibody (DFA) Test Product Picture
Figure 4. Immunochromatographic Assay Product Picture
Figure 5. RT-PCR-Based Test Product Picture
Figure 6. Agglutination Assay Product Picture
Figure 7. Flow-Through Assay Product Picture
Figure 8. Solid-Phase Assay Product Picture
Figure 9. Global Viral Testing Market Share by Application in 2020 & 2027
Figure 10. Laboratory
Figure 11. Hospital
Figure 12. Home Care
Figure 13. Academic Institute
Figure 14. Global Viral Testing Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Viral Testing Market Size 2016-2027 (US$ Million)
Figure 16. Global Viral Testing Sales 2016-2027 (K Units)
Figure 17. Global Viral Testing Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Viral Testing Sales Share by Manufacturers in 2020
Figure 19. Global Viral Testing Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Viral Testing Players: Market Share by Revenue in 2020
Figure 21. Viral Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Viral Testing Sales Market Share by Region (2016-2021)
Figure 23. Global Viral Testing Sales Market Share by Region in 2020
Figure 24. Global Viral Testing Revenue Market Share by Region (2016-2021)
Figure 25. Global Viral Testing Revenue Market Share by Region in 2020
Figure 26. U.S. Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. UAE Viral Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Viral Testing by Type (2016-2021)
Figure 51. Sales Market Share of Viral Testing by Application (2016-2021)
Figure 52. Sales Market Share of Viral Testing by Application in 2020
Figure 53. Revenue Share of Viral Testing by Application (2016-2021)
Figure 54. Revenue Share of Viral Testing by Application in 2020
Figure 55. Manufacturing Cost Structure of Viral Testing
Figure 56. Manufacturing Process Analysis of Viral Testing
Figure 57. Viral Testing Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs